Verve Therapeutics (VERV) Stock Price

$11.13 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    8
  • Fundamental

    1
  • Technical

    8

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Verve Therapeutics, AI stock picks, stock alerts and much more.

Sign up

VERV AI Stock Analysis

AI stock analysis for VERV is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Verve Therapeutics (VERV) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Verve Therapeutics (VERV) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Verve Therapeutics (VERV), currently trading at $11.13, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About VERV

LSE
  • Verve Therapeutics, Inc.

  • Symbol

    VERV

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    994M

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$21.28
0.1%
7
INO Inovio Pharmaceuticals
INO
$1.41
2.1%
2
MRNA Moderna
MRNA
$29.39
8.6%
3
AVXL Anavex Life Sciences
AVXL
$11.32
1.3%
5
BBIO BridgeBio Pharma
BBIO
$47.06
3.2%
6

VERV Alternative Data

Web Traffic

Verve Therapeutics receives an estimated 32950 monthly visitors to vervetx.com.

  • Web Traffic

    32950

  • Change from Previous Month

    86.6%

  • 3 Month Change

    91.2%

  • YoY Change

    91.2%

LinkedIn Followers

40,178 are following Verve Therapeutics on LinkedIn, up by 1.3% over the last month.

  • LinkedIn Followers

    40178

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    7%

Job Postings

Verve Therapeutics currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

  • YoY Change

    100%

LinkedIn Employees

According to LinkedIn, Verve Therapeutics has 308 employees.

  • LinkedIn Employees

    308

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

Reddit Mentions

Verve Therapeutics has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    2

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Verve Therapeutics has 5,159 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.

  • Twitter Followers

    5159

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    2.7%

  • YoY Change

    2.7%

Business Outlook

According to employee reviews, the business outlook among employees at Verve Therapeutics is 75 out of 100 (bullish), up by 5.6% over the last month.

  • Business Outlook

    75

  • Change from Previous Month

    5.6%

  • 3 Month Change

    8.5%

  • YoY Change

    8.5%

News Mentions

Verve Therapeutics was mentioned 2 times in the news yesterday.

  • News Mentions

    2

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

VERV Financials

VERV Key Metrics
  • Total Revenue

    $13.1M

  • Net Income

    -$50M

  • Earnings per Share

    -$0.58

  • Free cash flow

    -$42.2M

  • EBITDA

    -$54.4M

  • EBITDA Ratio

    -4.1565

  • Total Assets

    $647.4M

VERV 2-year Revenue & Income
VERV 2-year Free Cash Flow

VERV Technicals

VERV SMA
VERV RSI

FAQ

What's the current price of Verve Therapeutics (VERV) Stock?
The price of an Verve Therapeutics (VERV) share is $11.13.

What's the market cap of Verve Therapeutics?
The current market cap of Verve Therapeutics is 994M.

Should I buy or sell VERV?
Multiple alternative data signals suggest that Verve Therapeutics stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Verve Therapeutics a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Verve Therapeutics stock. The bullish indicators suggest that Verve Therapeutics' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Verve Therapeutics (VERV) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Verve Therapeutics stock, given the bullish outlook.

What are some stocks similar to Verve Therapeutics (VERV) that investors often compare it to?
Verve Therapeutics (VERV) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Verve Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Verve Therapeutics' stock price to be around $11.84 in 2026. Starting from the current price of $11.13, this represents a 6.4% change in price, indicating a bullish outlook for the stock.

How to buy Verve Therapeutics (VERV) Stock?
Verve Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Verve Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.